Chorea--an unusual manifestation in a woman recovering from myxedema coma.
OBJECTIVE
To report a case of reversible chorea in a woman with myxedema coma.


METHODS
We describe the clinical course, imaging findings, and laboratory test results of a patient who initially presented with myxedema coma and then developed reversible chorea upon treatment.


RESULTS
A 33-year-old woman with a known history of primary hypothyroidism presented with a 3-week history of lethargy, progressing to a precipitous decline in consciousness that required intubation. Physical examination revealed concurrent hypothermia and bradycardia. Laboratory investigations demonstrated a thyrotropin concentration greater than 100 mIU/L, a free triiodothyronine concentration of 1.9 pg/mL, and a free thyroxine concentration of 0.24 ng/dL, but no other metabolic abnormalities. She was treated with intravenous levothyroxine therapy on the first 2 days of hospital admission (200 mcg and 250 mcg, respectively). On day 2, she was obeying commands and she was extubated. She began exhibiting choreiform movements. Thyroid function test results revealed a normal free thyroxine concentration (1.10 ng/dL), but an elevated thyrotropin concentration (40.98 mIU/L) and a low free triiodothyronine concentration (1.9 pg/mL). Findings from computed tomography and magnetic resonance imaging of her brain and analysis of cerebrospinal fluid were normal. Her regimen was transitioned to oral levothyroxine, 88 mcg daily, and by day 4, her choreiform movements ceased.


CONCLUSIONS
Neurologic manifestations of hypothyroidism include psychomotor slowing, memory deficits, and dementia, with myxedema coma at the extreme of this spectrum. Although chorea is a rare manifestation of hyperthyroidism, this is the first report of a patient with acquired, reversible choreiform movement disorder while still being severely hypothyroid and treated with levothyroxine.
Division of Endocrinology and Metabolism, Faculty of Medicine, Toronto Western Hospital, University of Toronto, Toronto, Canada. yuca@smh.ca
Catherine H Y
CH
Yu
Rebecca
R
Stovel
Susan
S
Fox
D000328:Adult; D001919:Bradycardia / Q000209:etiology / Q000517:prevention & control; D002819:Chorea / Q000209:etiology / Q000517:prevention & control*; D003128:Coma / Q000209:etiology / Q000517:prevention & control*; D003937:Diagnosis, Differential; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D007035:Hypothermia / Q000209:etiology / Q000517:prevention & control; D007037:Hypothyroidism / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D009230:Myxedema / Q000209:etiology / Q000517:prevention & control*; D012720:Severity of Illness Index; D013974:Thyroxine / Q000097:blood / Q000627:therapeutic use*; D016896:Treatment Outcome; D014284:Triiodothyronine / Q000097:blood
D014284:Triiodothyronine; D013974:Thyroxine